SCHEMBL22705474

SCHEMBL22705474

CC(C)(Oc1ccc(Cl)cc1)C(=O)N1CCCC1c1cccc(F)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 3/20 0.67
LMNA P02545 3/20 0.46
PSEN1 P49768 2/20 0.44
PSEN2 P49810 2/20 0.44
APH1B Q8WW43 2/20 0.44
NCSTN Q92542 2/20 0.44
APH1A Q96BI3 2/20 0.44
PSENEN Q9NZ42 2/20 0.44
OPRK1 P41145 4/20 0.44
OPRM1 P35372 3/20 0.44
OPRD1 P41143 2/20 0.44
TSHR P16473 2/20 0.44
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22705466 0.91 RIPK1 (0.53) RIPK1LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL22705455 0.89 RIPK1 (0.51) RIPK1LMNAOPRK1TSHRALDH1A1
SCHEMBL22705484 0.87 LMNA (0.48) RIPK1LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL22705447 0.87 RIPK1 (0.63) RIPK1LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL22705507 0.87 RIPK1 (0.63) RIPK1LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL22705434 0.86 RIPK1 (0.53) RIPK1LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL22705438 0.82 LMNA (0.52) RIPK1LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL22705476 0.82 LMNA (0.52) RIPK1LMNATSHRALDH1A1SMN1; SMN2
SCHEMBL22705392 0.80 LMNA (0.53) RIPK1LMNAOPRK1OPRM1TSHR
SCHEMBL22705464 0.79 LMNA (0.51) RIPK1LMNATSHRALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213077-A1 INHIBITORS FOR PROGRAMMED CELL NECROSIS AND PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2022-07-07 US disclosed
WO-2020233618-A1 INHIBITORS FOR PROGRAMMED CELL NECROSIS AND PREPARATION METHOD THEREFOR AND USE THEREOF 中国科学院上海有机化学研究所 (CN) 2020-11-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213077-A1 INHIBITORS FOR PROGRAMMED CELL NECROSIS AND PREPARATION METHOD THEREFOR AND USE THEREOF LITAF, TNF, BAD RIPK1 146/4885LMNA 343/4885PSEN1 290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.